The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial

Lancet

Volumn 369, Issue 9566, 2007, Pages 1016-1026

  Marson, Anthony G ^a   Al Kharusi, Asya M ^d   Alwaidh, Muna ^e   Appleton, Richard ^b   Baker, Gus A ^a   Chadwick, David W ^a   Cramp, Celia ^f   Cockerell, Oliver C ^g   Cooper, Paul N ^h   Doughty, Julie ^c   Eaton, Barbara ^a   Gamble, Carrol ^a   Goulding, Peter J ⁱ   Howell, Stephen JL ^j   Hughes, Adrian ^k   Jackson, Margaret ^l   Jacoby, Ann ^a   Kellett, Mark ^h   Lawson, Geoffrey R ^m   Leach, John Paul ⁿ   Nicolaides, Paola ^o   Roberts, Richard ^p   Shackley, Phil ^c   Shen, Jing ^c   Smith, David F ^q   Smith, Philip EM ^r   Smith, Catrin Tudur ^a   Vanoli, Alessandra ^c   Williamson, Paula R ^a   more..

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d SOUTHPORT AND ORMSKIRK HOSPITAL NHS TRUST   (United Kingdom)

^e WHISTON HOSPITAL   (United Kingdom)

^f ROYAL SHREWSBURY HOSPITAL   (United Kingdom)

^g ROYAL LONDON HOSPITAL   (United Kingdom)

^h ROYAL BOLTON HOSPITAL   (United Kingdom)

ⁱ LEEDS GENERAL INFIRMARY   (United Kingdom)

^j ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^k ARROWE PARK HOSPITAL   (United Kingdom)

^l ROYAL VICTORIA INFIRMARY   (United Kingdom)

^m SUNDERLAND ROYAL HOSPITAL   (United Kingdom)

ⁿ SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^o GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^p NINEWELLS HOSPITAL   (United Kingdom)

^q WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^r UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LAMOTRIGINE; TOPIRAMATE; VALPROIC ACID;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; EPILEPSY; FEMALE; FOLLOW UP; GENERALIZED EPILEPSY; GRAND MAL SEIZURE; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; TREATMENT OUTCOME; UNITED KINGDOM;

ADOLESCENT; ADULT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; EPILEPSY, GENERALIZED; FEMALE; FOLLOW-UP STUDIES; FRUCTOSE; HUMANS; MALE; QUALITY-ADJUSTED LIFE YEARS; TIME FACTORS; TREATMENT FAILURE; TRIAZINES; VALPROIC ACID;

EID: 33947228816     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)60461-9     Document Type: Article

References (25)

1. Hauser W., and Hesdorffer D. Epilepsy: frequency, causes and consequences (1990), Demos Publications, New York
2. Anon. Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 30 (1989) 389-399
3. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 22 (1981) 489-501
4. The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care (2004), National Institute for Clinical Excellence, London Clinical Guideline 20.
5. French J., Kanner A., Bautista J., et al. Efficacy and tolerability of the new antiepileptic drugs i: treatment of new onset epilepsy: report of the therapeutics and technology assessment subcommittee and quality standards subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 62 (2004) 1252-1260
6. Marson A., Williamson P., Clough H., Hutton J., and Chadwick D. Carbamazepine versus valproate monotherapy for epilepsy: a meta-analysis. Epilepsia 43 (2002) 505-513
7. Tudur Smith C., Marson A., and Williamson P. Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures. Cochrane Database Syst Rev 4 (2001) CD001769.
8. Posner E., Mohamed K., and Marson A. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents. Cochrane Database Syst Rev 4 (2005) CD003032.
9. Nicolson A., Appleton R., Chadwick D., and Smith D. The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies. J Neurol Neurosurg Psychiatry 75 (2004) 75-79
10. Shields W., and Saslow E. Myoclonic, atonic, and absence seizures following institution of carbamazepine therapy in children. Neurology 33 (1983) 1487-1489
11. Snead O., and Hosey L. Exacerbation of seizures in children by carbamazepine. N Engl J Med 313 (1985) 916-921
12. Adab N., Kini U., Vinten J., et al. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 75 (2004) 1575-1583
13. Morrow J., Russell A., Guthrie E., et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 77 (2006) 193-198
14. Biton V., Sackellares J., Vuong A., Hammer A., Barrett P., and Messenheimer J. Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures. Neurology 65 (2005) 1737-1743
15. Beran R., Berkovic S., Dunagan F., et al. Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant generalised epilepsy. Epilepsia 39 (1998) 1329-1333
16. Eriksson A., Nergardh A., and Hoppu K. The efficacy of lamotrigine in children and adolescents with refractory generalized epilepsy: a randomized, double-blind, crossover study. Epilepsia 39 (1998) 495-501
17. Motte J., Trevathan E., Arvidsson J., Barrera M., Mullens E., and Manasco P. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group. N Engl J Med 337 (1997) 1807-1812
18. Privitera M., Brodie M., Mattson R., et al. Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurol Scand 107 (2003) 165-175
19. Newer drugs for epilepsy in adults (2004), National Institute for Clinical Excellence, London Technology Appraisal Guidance 76.
20. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30 (1989) 389-399
21. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 22 (1981) 489-501
22. Marson A., Al-Kharusi A., Alwaidh M., et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 369 (2007) 1000-1015
23. Medical Research Council. Guidelines for good clinical practice in clinical trials (1998), MRC, London
24. Brodie M., Richens A., and Yuen A. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Lancet 345 (1995) 476-479
25. Adab N., Kini U., Vinten J., et al. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 75 (2004) 1575-1583